Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

RNA Splicing01:32

RNA Splicing

56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Testosterone replacement therapy increases 2 and 5 year reoperation rates after posterior lumbar fusion: a propensity-matched analysis of 1808 surgical patients.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute Leukemias.

Cancer discovery·2026
Same author

Circadian chronotype distribution among young adults in Yemen.

Chronobiology international·2026
Same author

CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis.

Nature genetics·2026
Same author

Pubic bone osteomyelitis outcomes in patients with malignancies: a case series from an academic cancer center.

Journal of bone and joint infection·2026
Same author

Disorders of the coccyx and sacrococcygeal joint: Etiology, diagnosis, and management strategies.

The American journal of medicine·2025

相关实验视频

Updated: Jun 27, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

9.9K

在血液性恶性瘤中,GPATCH8调节突变SF3B1的错误拼接和致病性.

Salima Benbarche1, Jose Mario Bello Pineda2, Laura Baquero Galvis3

  • 1Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Molecular cell
|April 30, 2024
PubMed
概括

SF3B1中的突变通过改变RNA拼接而导致癌症. 研究人员确定GPATCH8是这种错误拼接的关键因素,并且使其保持沉默改善了癌症模型,提供了潜在的治疗策略.

关键词:
DHX15 DHX15 的时间.G-补丁域名域名在GPATCH8中使用.这是一个RNARNARNARNARNA.在SF3B1中.在 SUGP1 中,这种白血病是白血病.骨髓发育不良综合征拼接 拼接 拼接 拼接

更多相关视频

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K

相关实验视频

Last Updated: Jun 27, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

9.9K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K

科学领域:

  • 分子生物学分子生物学
  • 癌症遗传学 癌症遗传学
  • RNA拼接机制的机制

背景情况:

  • 在各种癌症中,SF3B1基因的突变很普遍,导致广泛的RNA错误拼接.
  • 目前的疗法无法有效地纠正SF3B1突变诱导的拼接缺陷.

研究的目的:

  • 确定涉及突变SF3B1.1.驱动的异常拼接的转作用因子.
  • 探索针对这些因素在SF3B1突变癌症中的治疗潜力.

主要方法:

  • 利用对突变SF3B1有反应的合成内子来选相互作用的转变因子.
  • 使用基因沉默技术来评估已识别的因素的作用.
  • 在小鼠模型和人类祖先中对血液形成的评估影响.

主要成果:

  • 确定GPATCH8为突变SF3B1介导的剪接变化和血液形成受损的关键因素.
  • GPATCH8与DHX15相互作用,并对抗SUGP1,影响分支点选择.
  • 沉默GPATCH8纠正了相当一部分SF3B1依赖的拼接缺陷,并改善了血液形成.

结论:

  • GPATCH8是一种新型拼接因子,对SF3B1-突变相关的错误拼接至关重要.
  • 向GPATCH8显示出对纠正SF3B1-突变癌症异常拼接的治疗前景.